Institutional investors purchased a net $270.8 thousand shares of PCRX during the quarter ended December 2015 and now own 116.41% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE TEACHERS RETIREMENT SYSTEM... Bought 97.2 Thousand shares of Pacira Pharmaceuticals In...
FRANKLIN STREET ADVISORS, INC. Bought 6.1 Thousand shares of Pacira Pharmaceuticals In...